Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia

Background: Percutaneous coronary intervention (PCI) in stable ischaemic heart disease (SIHD) has not been shown to improve prognosis but can alleviate symptoms and improve quality of life. Appropriately selected patients with symptoms refractory to medical therapy therefore stand to benefit, provid...

Full description

Bibliographic Details
Main Authors: Hamilton, G.W., Yeoh, J., Dinh, D., Reid, Christopher, Yudi, M.B., Freeman, M., Brennan, A., Stub, D., Oqueli, E., Sebastian, M., Duffy, S.J., Horrigan, M., Farouque, O., Ajani, A., Clark, D.J.
Format: Journal Article
Language:English
Published: 2022
Subjects:
Online Access:http://purl.org/au-research/grants/nhmrc/1136372
http://hdl.handle.net/20.500.11937/93768
_version_ 1848765784635998208
author Hamilton, G.W.
Yeoh, J.
Dinh, D.
Reid, Christopher
Yudi, M.B.
Freeman, M.
Brennan, A.
Stub, D.
Oqueli, E.
Sebastian, M.
Duffy, S.J.
Horrigan, M.
Farouque, O.
Ajani, A.
Clark, D.J.
author_facet Hamilton, G.W.
Yeoh, J.
Dinh, D.
Reid, Christopher
Yudi, M.B.
Freeman, M.
Brennan, A.
Stub, D.
Oqueli, E.
Sebastian, M.
Duffy, S.J.
Horrigan, M.
Farouque, O.
Ajani, A.
Clark, D.J.
author_sort Hamilton, G.W.
building Curtin Institutional Repository
collection Online Access
description Background: Percutaneous coronary intervention (PCI) in stable ischaemic heart disease (SIHD) has not been shown to improve prognosis but can alleviate symptoms and improve quality of life. Appropriately selected patients with symptoms refractory to medical therapy therefore stand to benefit, provided safety is proven. Methods: Consecutive patients undergoing PCI for SIHD between 2005–2018 in a prospective registry were included. Yearly comparisons evaluated trends, and a sub-analysis was performed comparing proximal left anterior descending artery (prox-LAD) to other-than-proximal LAD (non-pLAD) PCI. Outcomes included peri-procedural characteristics, in-hospital and 30-day event rates including MACE, and 5-year National Death Index (NDI) linked mortality. Results: There were 9,421 procedures included. Over time, patients were increasingly co-morbid and had higher rates of AHA/ACC class B2/C lesions, ostial stenoses, bifurcation lesions, and chronic total occlusions (all p-for-trend ≤0.001). Over 14 years, major bleeding reduced (1.05% in 2005/06 vs 0.29% in 2017/18, p-for-trend <0.001), while other in-hospital and 30-day event rates were stably low. There were only seven (0.07%) in hospital deaths and 5-year mortality was 10.3%. No differences were found in outcomes between patients who underwent prox-LAD compared to non-pLAD PCI. Major independent predictors of NDI linked all-cause mortality included an eGFR <30 mL/min/1.73 m2 (HR 4.06, 95% CI 3.26–5.06), chronic obstructive pulmonary disease (COPD) (HR 2.25, 95% CI 1.89–2.67) and LVEF <30% (HR 2.13, 95% CI 1.57–2.89). Conclusions: Although patient and procedural complexity increased over time, a high degree of procedural success and safety was maintained, including in those undergoing prox-LAD PCI. These real-world data can enhance shared decision making discussions regarding whether PCI should be pursued in patients with symptomatic SIHD refractory to medical therapy.
first_indexed 2025-11-14T11:40:45Z
format Journal Article
id curtin-20.500.11937-93768
institution Curtin University Malaysia
institution_category Local University
language eng
last_indexed 2025-11-14T11:40:45Z
publishDate 2022
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-937682024-01-11T02:04:08Z Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia Hamilton, G.W. Yeoh, J. Dinh, D. Reid, Christopher Yudi, M.B. Freeman, M. Brennan, A. Stub, D. Oqueli, E. Sebastian, M. Duffy, S.J. Horrigan, M. Farouque, O. Ajani, A. Clark, D.J. Outcomes Percutaneous coronary intervention Real-world Safety Stable ischaemic heart disease Humans Percutaneous Coronary Intervention Quality of Life Coronary Artery Disease Myocardial Ischemia Australia Melbourne Interventional Group Registry Humans Myocardial Ischemia Quality of Life Australia Coronary Artery Disease Percutaneous Coronary Intervention Background: Percutaneous coronary intervention (PCI) in stable ischaemic heart disease (SIHD) has not been shown to improve prognosis but can alleviate symptoms and improve quality of life. Appropriately selected patients with symptoms refractory to medical therapy therefore stand to benefit, provided safety is proven. Methods: Consecutive patients undergoing PCI for SIHD between 2005–2018 in a prospective registry were included. Yearly comparisons evaluated trends, and a sub-analysis was performed comparing proximal left anterior descending artery (prox-LAD) to other-than-proximal LAD (non-pLAD) PCI. Outcomes included peri-procedural characteristics, in-hospital and 30-day event rates including MACE, and 5-year National Death Index (NDI) linked mortality. Results: There were 9,421 procedures included. Over time, patients were increasingly co-morbid and had higher rates of AHA/ACC class B2/C lesions, ostial stenoses, bifurcation lesions, and chronic total occlusions (all p-for-trend ≤0.001). Over 14 years, major bleeding reduced (1.05% in 2005/06 vs 0.29% in 2017/18, p-for-trend <0.001), while other in-hospital and 30-day event rates were stably low. There were only seven (0.07%) in hospital deaths and 5-year mortality was 10.3%. No differences were found in outcomes between patients who underwent prox-LAD compared to non-pLAD PCI. Major independent predictors of NDI linked all-cause mortality included an eGFR <30 mL/min/1.73 m2 (HR 4.06, 95% CI 3.26–5.06), chronic obstructive pulmonary disease (COPD) (HR 2.25, 95% CI 1.89–2.67) and LVEF <30% (HR 2.13, 95% CI 1.57–2.89). Conclusions: Although patient and procedural complexity increased over time, a high degree of procedural success and safety was maintained, including in those undergoing prox-LAD PCI. These real-world data can enhance shared decision making discussions regarding whether PCI should be pursued in patients with symptomatic SIHD refractory to medical therapy. 2022 Journal Article http://hdl.handle.net/20.500.11937/93768 10.1016/j.hlc.2022.08.019 eng http://purl.org/au-research/grants/nhmrc/1136372 restricted
spellingShingle Outcomes
Percutaneous coronary intervention
Real-world
Safety
Stable ischaemic heart disease
Humans
Percutaneous Coronary Intervention
Quality of Life
Coronary Artery Disease
Myocardial Ischemia
Australia
Melbourne Interventional Group Registry
Humans
Myocardial Ischemia
Quality of Life
Australia
Coronary Artery Disease
Percutaneous Coronary Intervention
Hamilton, G.W.
Yeoh, J.
Dinh, D.
Reid, Christopher
Yudi, M.B.
Freeman, M.
Brennan, A.
Stub, D.
Oqueli, E.
Sebastian, M.
Duffy, S.J.
Horrigan, M.
Farouque, O.
Ajani, A.
Clark, D.J.
Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title_full Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title_fullStr Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title_full_unstemmed Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title_short Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
title_sort trends and real-world safety of patients undergoing percutaneous coronary intervention for symptomatic stable ischaemic heart disease in australia
topic Outcomes
Percutaneous coronary intervention
Real-world
Safety
Stable ischaemic heart disease
Humans
Percutaneous Coronary Intervention
Quality of Life
Coronary Artery Disease
Myocardial Ischemia
Australia
Melbourne Interventional Group Registry
Humans
Myocardial Ischemia
Quality of Life
Australia
Coronary Artery Disease
Percutaneous Coronary Intervention
url http://purl.org/au-research/grants/nhmrc/1136372
http://hdl.handle.net/20.500.11937/93768